Post-transcriptional regulation in metabolic diseases

RNA Biology

Volumn 9, Issue 6, 2012, Pages 772-780

  Kim, Wook ^a   Lee, Eun Kyung ^b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b The Catholic University of Korea   (South Korea)

Author keywords

Diabetes; Glucose homeostasis; Lipid homeostasis; Metabolic disease; microRNAs; Post transcriptional gene regulation; RNA binding proteins

Indexed keywords

CHOLESTEROL; GLUCOSE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE; LIN28 PROTEIN; MICRORNA; MICRORNA 375; MICRORNA 378; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B; RNA BINDING PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ADIPOGENESIS; ANIMAL CELL; APOPTOSIS; CELL CYCLE REGULATION; CELL PROLIFERATION; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; FATTY ACID OXIDATION; GENE OVEREXPRESSION; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN CELL; INSULIN RELEASE; INSULIN SENSITIVITY; INSULIN SYNTHESIS; LIPID METABOLISM; METABOLIC DISORDER; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; POSTTRANSCRIPTIONAL GENE SILENCING; RAT; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 84863521940     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.20091     Document Type: Review

References (106)

1. Permutt MA, Wasson J, Cox N. Genetic epidemiology of diabetes. J Clin Invest 2005; 115:1431-9; PMID:15931378; http://dx.doi.org/10.1172/JCI24758.
2. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 1993; 329:1988-92; PMID:8247074; http://dx.doi.org/10.1056/ NEJM199312303292703.
3. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001; 414:799-806; PMID:11742412; http://dx.doi.org/ 10.1038/414799a.
4. Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J Am Coll Nutr 2003; 22:331-9; PMID:14559925.
5. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433:769-73; PMID:15685193; http://dx.doi.org/10.1038/ nature03315.
6. Chekulaeva M, Filipowicz W. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol 2009; 21:452-60; PMID:19450959; http://dx.doi.org/10.1016/j.ceb.2009.04.009.
7. Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010; 79:351-79; PMID:20533884; http://dx.doi.org/10.1146/annurev-biochem-060308-103103.
8. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can upregulate translation. Science 2007; 318:1931-4; PMID:18048652; http://dx.doi.org/10.1126/science.1149460.
9. Ørom UA, Nielsen FC, Lund AH. MicroRNA-10a binds the 5′ UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 2008; 30:460-71; PMID:18498749; http://dx.doi.org/10.1016/j.molcel.2008.05.001.
10. Henke JI, Goergen D, Zheng J, Song Y, Schüttler CG, Fehr C, et al. microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J 2008; 27:3300-10; PMID:19020517; http://dx.doi.org/10.1038/emboj.2008.244.
11. Abdelmohsen K, Kuwano Y, Kim HH, Gorospe M. Posttranscriptional gene regulation by RNA-binding proteins during oxidative stress: implications for cellular senescence. Biol Chem 2008; 389:243-55; PMID:18177264; http://dx.doi.org/10.1515/BC.2008.022.
12. Lunde BM, Moore C, Varani G. RNA-binding proteins: modular design for efficient function. Nat Rev Mol Cell Biol 2007; 8:479-90; PMID:17473849; http://dx.doi.org/10.1038/nrm2178.
13. Lee EK, Gorospe M. Coding region: the neglected post-transcriptional code. RNA Biol 2011; 8:44-8; PMID:21289484; http://dx.doi.org/10.4161/rna.8.1. 13863.
14. Abdelmohsen K, Tominaga K, Lee EK, Srikantan S, Kang MJ, Kim MM, et al. Enhanced translation by Nucleolin via G-rich elements in coding and noncoding regions of target mRNAs. Nucleic Acids Res 2011; 39:8513-30; PMID:21737422; http://dx.doi.org/10.1093/nar/gkr488.
15. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 1998; 391:900-4; PMID:9495343; http://dx.doi.org/10.1038/36116.
16. Kulkarni RN, Brüning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 1999; 96:329-39; PMID:10025399; http://dx.doi.org/10.1016/S0092-8674(00)80546-2.
17. Kulkarni RN, Winnay JN, Daniels M, Brüning JC, Flier SN, Hanahan D, et al. Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. J Clin Invest 1999; 104:69-75; PMID:10606633; http://dx.doi.org/10.1172/JCI8339.
18. Uchida T, Nakamura T, Hashimoto N, Matsuda T, Kotani K, Sakaue H, et al. Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat Med 2005; 11:175-82; PMID:15685168; http://dx.doi.org/10.1038/nm1187.
19. Ebina Y, Ellis L, Jarnagin K, Edery M, Graf L, Clauser E, et al. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell 1985; 40:747-58; PMID:2859121; http://dx.doi.org/10.1016/0092-8674(85)90334-4.
20. Ullrich A, Bell JR, Chen EY, Herrera R, Petruzzelli LM, Dull TJ, et al. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 1985; 313:756-61; PMID:2983222; http://dx.doi.org/10.1038/ 313756a0.
21. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 2000; 6:87-97; PMID:10949030.
22. Fernández AM, Kim JK, Yakar S, Dupont J, Hernandez-Sanchez C, Castle AL, et al. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev 2001; 15:1926-34; PMID:11485987; http://dx.doi.org/10.1101/gad.908001.
23. Miyake K, Ogawa W, Matsumoto M, Nakamura T, Sakaue H, Kasuga M. Hyperinsulinemia, glucose intolerance and dyslipidemia induced by acute inhibition of phosphoinositide-3-kinase signaling in the liver. J Clin Invest 2002; 110:1483-91; PMID:12438446.
24. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004; 432:226-30; PMID:15538371; http://dx.doi.org/10.1038/nature03076.
25. El Ouaamari A, Baroukh N, Martens GA, Lebrun P, Pipeleers D, van Obberghen E. miR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes 2008; 57:2708-17; PMID:18591395; http://dx.doi.org/10.2337/ db07-1614.
26. Keller DM, McWeeney S, Arsenlis A, Drouin J, Wright CV, Wang H, et al. Characterization of pancreatic transcription factor Pdx-1 binding sites using promoter microarray and serial analysis of chromatin occupancy. J Biol Chem 2007; 282:32084-92; PMID:17761679; http://dx.doi.org/10.1074/jbc.M700899200.
27. Zhao E, Keller MP, Rabaglia ME, Oler AT, Stapleton DS, Schueler KL, et al. Obesity and genetics regulate microRNAs in islets, liver and adipose of diabetic mice. Mamm Genome 2009; 20:476-85; PMID:19727952; http://dx.doi.org/10. 1007/s00335-009-9217-2.
28. Poy MN, Hausser J, Trajkovski M, Braun M, Collins S, Rorsman P, et al. miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci USA 2009; 106:5813-8; PMID:19289822; http://dx.doi.org/10.1073/pnas. 0810550106.
29. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, et al. RAS is regulated by the let-7 microRNA family. Cell 2005; 120:635-47; PMID:15766527; http://dx.doi.org/10.1016/j.cell.2005.01.014.
30. Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 2007; 21:1025-30; PMID:17437991; http://dx.doi.org/10.1101/ gad.1540407.
31. Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007; 315:1576-9; PMID:17322030; http://dx.doi.org/10.1126/science.1137999.
32. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA 2008; 105:3903-8; PMID:18308936; http://dx.doi.org/10.1073/pnas.0712321105.
33. Heo I, Joo C, Cho J, Ha M, Han J, Kim VN. Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol Cell 2008; 32:276-84; PMID:18951094; http://dx.doi.org/10.1016/j.molcel.2008.09.014.
34. Viswanathan SR, Daley GQ, Gregory RI. Selective blockade of microRNA processing by Lin28. Science 2008; 320:97-100; PMID:18292307; http://dx.doi.org/10.1126/science.1154040.
35. Viswanathan SR, Powers JT, Einhorn W, Hoshida Y, Ng TL, Toffanin S, et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet 2009; 41:843-8; PMID:19483683; http://dx.doi.org/10. 1038/ng.392.
36. Zhu H, Shyh-Chang N, Segrè AV, Shinoda G, Shah SP, Einhorn WS, et al.; DIAGRAM Consortium; MAGIC Investigators. The Lin28/let-7 axis regulates glucose metabolism. Cell 2011; 147:81-94; PMID:21962509; http://dx.doi.org/10. 1016/j.cell.2011.08.033.
37. Guay C, Roggli E, Nesca V, Jacovetti C, Regazzi R. Diabetes mellitus, a microRNA-related disease? Transl Res 2011; 157:253-64; PMID:21420036; http://dx.doi.org/10.1016/j.trsl.2011.01.009.
38. Trajkovski M, Hausser J, Soutschek J, Bhat B, Akin A, Zavolan M, et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 2011; 474:649-53; PMID:21654750; http://dx.doi.org/10.1038/nature10112.
39. Jordan SD, Krüger M, Willmes DM, Redemann N, Wunderlich FT, Brönneke HS, et al. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol 2011; 13:434-46; PMID:21441927; http://dx.doi.org/10.1038/ncb2211.
40. Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, Ravichandran LV, et al. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 2004; 279:52361-5; PMID:15504739; http://dx.doi.org/10.1074/jbc.C400438200.
41. Xie H, Lim B, Lodish HF. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 2009; 58:1050-7; PMID:19188425; http://dx.doi.org/10.2337/db08-1299.
42. Takanabe R, Ono K, Abe Y, Takaya T, Horie T, Wada H, et al. Upregulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet. Biochem Biophys Res Commun 2008; 376:728-32; PMID:18809385; http://dx.doi.org/10.1016/j.bbrc.2008.09.050.
43. Li S, Chen X, Zhang H, Liang X, Xiang Y, Yu C, et al. Differential expression of microRNAs in mouse liver under aberrant energy metabolic status. J Lipid Res 2009; 50:1756-65; PMID:19372595; http://dx.doi.org/10.1194/jlr. M800509-JLR200.
44. Gallagher IJ, Scheele C, Keller P, Nielsen AR, Remenyi J, Fischer CP, et al. Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med 2010; 2:9; PMID:20353613; http://dx.doi.org/10.1186/gm130.
45. Lee EK, Gorospe M. Minireview: posttranscriptional regulation of the insulin and insulin-like growth factor systems. Endocrinology 2010; 151:1403-8; PMID:20032049; http://dx.doi.org/10.1210/en.2009-1123.
46. Melkman-Zehavi T, Oren R, Kredo-Russo S, Shapira T, Mandelbaum AD, Rivkin N, et al. miRNAs control insulin content in pancreatic β-cells via downregulation of transcriptional repressors. EMBO J 2011; 30:835-45; PMID:21285947; http://dx.doi.org/10.1038/emboj.2010.361.
47. Kulkarni SD, Muralidharan B, Panda AC, Bakthavachalu B, Vindu A, Seshadri V. Glucose-stimulated translation regulation of insulin by the 5′ UTR-binding proteins. J Biol Chem 2011; 286:14146-56; PMID:21357685; http://dx.doi.org/10.1074/jbc.M110.190553.
48. Roggli E, Gattesco S, Pautz A, Regazzi R. Involvement of the RNA-binding protein ARE/poly(U)-binding factor 1 (AUF1) in the cytotoxic effects of proinflammatory cytokines on pancreatic beta cells. [Epup ahead of print]. Diabetologia 2011; PMID:22159912; http://dx.doi.org/10.1007/s00125-011-2399-7.
49. Tillmar L, Carlsson C, Welsh N. Control of insulin mRNA stability in rat pancreatic islets. Regulatory role of a 3′-untranslated region pyrimidine-rich sequence. J Biol Chem 2002; 277:1099-106; PMID:11696543; http://dx.doi.org/10.1074/jbc.M108340200.
50. Tillmar L, Welsh N. Hypoxia may increase rat insulin mRNA levels by promoting binding of the polypyrimidine tract-binding protein (PTB) to the pyrimidinerich insulin mRNA 3′-untranslated region. Mol Med 2002; 8:263-72; PMID:12359957.
51. Knoch KP, Bergert H, Borgonovo B, Saeger HD, Altkrüger A, Verkade P, et al. Polypyrimidine tract-binding protein promotes insulin secretory granule biogenesis. Nat Cell Biol 2004; 6:207-14; PMID:15039777; http://dx.doi.org/10. 1038/ncb1099.
52. Lee EK, Kim W, Tominaga K, Martindale JL, Yang X, Subaran SS, et al. RNA-binding protein HuD controls insulin translation. Mol Cell 2012; In press; PMID:22387028; http://dx.doi.org/10.1016/j.molcel.2012.01.016.
53. Szabo A, Dalmau J, Manley G, Rosenfeld M, Wong E, Henson J, et al. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 1991; 67:325-33; PMID:1655278; http://dx.doi.org/10.1016/0092-8674(91)90184-Z.
54. Okano HJ, Darnell RB. A hierarchy of Hu RNA binding proteins in developing and adult neurons. J Neurosci 1997; 17:3024-37; PMID:9096138.
55. Grundy SM. Absorption and metabolism of dietary cholesterol. Annu Rev Nutr 1983; 3:71-96; PMID:6357243; http://dx.doi.org/10.1146/annurev.nu.03. 070183.000443.
56. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997; 89:331-40; PMID:9150132; http://dx.doi.org/10.1016/S0092-8674(00)80213-5.
57. Peet DJ, Janowski BA, Mangelsdorf DJ. The LXRs: a new class of oxysterol receptors. Curr Opin Genet Dev 1998; 8:571-5; PMID:9794827; http://dx.doi.org/ 10.1016/S0959-437X(98)80013-0.
58. Tall AR, Yvan-Charvet L, Terasaka N, Pagler T, Wang N. HDL, ABC transporters and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab 2008; 7:365-75; PMID:18460328; http://dx.doi.org/10. 1016/j.cmet.2008.03.001.
59. Schroeder F. Fluorescence probes in metastatic B16 melanoma membranes. Biochim Biophys Acta 1984; 776:299-312; PMID:6477911; http://dx.doi.org/10.1016/ 0005-2736(84)90219-0.
60. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995; 15:551-61; PMID:7749869; http://dx.doi.org/10.1161/01.ATV.15.5.551.
61. Aikawa M, Libby P. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc Pathol 2004; 13:125-38; PMID:15081469; http://dx.doi.org/10.1016/S1054-8807(04)00004-3.
62. Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005; 438:685-9; PMID:16258535; http://dx.doi.org/10.1038/nature04303.
63. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006; 3:87-98; PMID:16459310; http://dx.doi.org/10.1016/j.cmet.2006.01. 005.
64. Elmén J, Lindow M, Silahtaroglu A, Bak M, Christensen M, Lind-Thomsen A, et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to upregulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 2008; 36:1153-62; PMID:18158304; http://dx.doi.org/10.1093/nar/gkm1113.
65. Marquart TJ, Allen RM, Ory DS, Baldán A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci USA 2010; 107:12228-32; PMID:20566875; http://dx.doi.org/10.1073/pnas.1005191107.
66. Rayner KJ, Suárez Y, Dávalos A, Parathath S, Fitzgerald ML, Tamehiro N, et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010; 328:1570-3; PMID:20466885; http://dx.doi.org/10.1126/ science.1189862.
67. Dávalos A, Goedeke L, Smibert P, Ramírez CM, Warrier NP, Andreo U, et al. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci USA 2011; 108:9232-7; PMID:21576456; http://dx.doi.org/10.1073/pnas.1102281108.
68. Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 2010; 328:1566-9; PMID:20466882; http://dx.doi.org/10.1126/ science.1189123.
69. Gerin I, Clerbaux LA, Haumont O, Lanthier N, Das AK, Burant CF, et al. Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation. J Biol Chem 2010; 285:33652-61; PMID:20732877; http://dx.doi.org/10.1074/jbc.M110.152090.
70. Gerin I, Bommer GT, McCoin CS, Sousa KM, Krishnan V, MacDougald OA. Roles for miRNA-378/378&z.ast; in adipocyte gene expression and lipogenesis. Am J Physiol Endocrinol Metab 2010; 299:198-206; PMID:20484008.
71. Gantt K, Cherry J, Tenney R, Karschner V, Pekala PH. An early event in adipogenesis, the nuclear selection of the CCAAT enhancer-binding protein beta (C/EBPbeta) mRNA by HuR and its translocation to the cytosol. J Biol Chem 2005; 280:24768-74; PMID:15863502; http://dx.doi.org/10.1074/jbc.M502011200.
72. Kawagishi H, Wakoh T, Uno H, Maruyama M, Moriya A, Morikawa S, et al. Hzf regulates adipogenesis through translational control of C/EBPalpha. EMBO J 2008; 27:1481-90; PMID:18418387.
73. Plaisance V, Abderrahmani A, Perret-Menoud V, Jacquemin P, Lemaigre F, Regazzi R. MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J Biol Chem 2006; 281:26932-42; PMID:16831872; http://dx.doi.org/10.1074/jbc.M601225200.
74. Sun LL, Jiang BG, Li WT, Zou JJ, Shi YQ, Liu ZM. MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Res Clin Pract 2011; 91:94-100; PMID:21146880; http://dx.doi.org/10. 1016/j.diabres.2010.11.006.
75. Roggli E, Britan A, Gattesco S, Lin-Marq N, Abderrahmani A, Meda P, et al. Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. Diabetes 2010; 59:978-86; PMID:20086228; http://dx.doi.org/10.2337/db09-0881.
76. Ruan Q, Wang T, Kameswaran V, Wei Q, Johnson DS, Matschinsky F, et al. The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death. Proc Natl Acad Sci USA 2011; 108:12030-5; PMID:21730150; http://dx.doi.org/10.1073/pnas.1101450108.
77. He A, Zhu L, Gupta N, Chang Y, Fang F. Overexpression of micro ribonucleic acid 29, highly upregulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol 2007; 21:2785-94; PMID:17652184; http://dx.doi.org/10.1210/me.2007-0167.
78. Tang X, Muniappan L, Tang G, Ozcan S. Identification of glucose-regulated miRNAs from pancreatic beta cells reveals a role for miR-30d in insulin transcription. RNA 2009; 15:287-93; PMID:19096044; http://dx.doi.org/10.1261/ rna.1211209.
79. Lovis P, Roggli E, Laybutt DR, Gattesco S, Yang JY, Widmann C, et al. Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes 2008; 57:2728-36; PMID:18633110; http://dx.doi.org/10.2337/db07-1252.
80. Lovis P, Gattesco S, Regazzi R. Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biol Chem 2008; 389:305-12; PMID:18177263; http://dx.doi.org/10.1515/BC.2008. 026.
81. Hennessy E, Clynes M, Jeppesen PB, O'Driscoll L. Identification of microRNAs with a role in glucose stimulated insulin secretion by expression profiling of MIN6 cells. Biochem Biophys Res Commun 2010; 396:457-62; PMID:20417623; http://dx.doi.org/10.1016/j.bbrc.2010.04.116.
82. Teleman AA, Maitra S, Cohen SM. Drosophila lacking microRNA miR-278 are defective in energy homeostasis. Genes Dev 2006; 20:417-22; PMID:16481470; http://dx.doi.org/10.1101/gad.374406.
83. Kim YJ, Hwang SJ, Bae YC, Jung JS. MiR-21 regulates adipogenic differentiation through the modulation of TGFbeta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells 2009; 27:3093-102; PMID:19816956.
84. Sun F, Wang J, Pan Q, Yu Y, Zhang Y, Wan Y, et al. Characterization of function and regulation of miR-24-1 and miR-31. Biochem Biophys Res Commun 2009; 380:660-5; PMID:19285018; http://dx.doi.org/10.1016/j.bbrc.2009.01.161.
85. Lin Q, Gao Z, Alarcon RM, Ye J, Yun Z. A role of miR-27 in the regulation of adipogenesis. FEBS J 2009; 276:2348-58; PMID:19348006; http://dx.doi.org/10. 1111/j.1742-4658.2009.06967.x.
86. Kim SY, Kim AY, Lee HW, Son YH, Lee GY, LeeJ W, et al. miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem Biophys Res Commun 2010; 392:323-8; PMID:20060380; http://dx.doi.org/10.1016/j.bbrc.2010.01.012.
87. Tang YF, Zhang Y, Li XY, Li C, Tian W, Liu L. Expression of miR-31, miR-125b-5p and miR-326 in the adipogenic differentiation process of adipose-derived stem cells. OMICS 2009; 13:331-6; PMID:19422302; http://dx.doi.org/10.1089/omi.2009.0017.
88. Xie H, Lim B, Lodish HF. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 2009; 58:1050-7; PMID:19188425; http://dx.doi.org/10.2337/db08-1299.
89. Wilfred BR, Wang WX, Nelson PT. Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol Genet Metab 2007; 91:209-17; PMID:17521938; http://dx.doi.org/10.1016/j.ymgme.2007.03.011.
90. Lee EK, Lee MJ, Abdelmohsen K, Kim W, Kim MM, Srikantan S, et al. miR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor gamma expression. Mol Cell Biol 2011; 31:626-38; PMID:21135128; http://dx.doi.org/10.1128/MCB.00894-10.
91. Yang Z, Bian C, Zhou H, Huang S, Wang S, Liao L, et al. MicroRNA hsa-miR-138 inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells through adenovirus EID-1. Stem Cells Dev 2011; 20:259-67; PMID:20486779; http://dx.doi.org/10.1089/scd.2010.0072.
92. Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, Ravichandran LV, et al. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 2004; 279:52361-5; PMID:15504739; http://dx.doi.org/10.1074/jbc.C400438200.
93. Whittaker R, Loy PA, Sisman E, Suyama E, Aza-Blanc P, Ingermanson RS, et al. Identification of MicroRNAs that control lipid droplet formation and growth in hepatocytes via high-content screening. J Biomol Screen 2010; 15:798-805; PMID:20639500; http://dx.doi.org/10.1177/1087057110374991.
94. Kennell JA, Gerin I, MacDougald OA, Cadigan KM. The microRNA miR-8 is a conserved negative regulator of Wnt signaling. Proc Natl Acad Sci USA 2008; 105:15417-22; PMID:18824696; http://dx.doi.org/10.1073/pnas.0807763105.
95. Qin L, Chen Y, Niu Y, Chen W, Wang Q, Xiao S, et al. A deep investigation into the adipogenesis mechanism: profile of microRNAs regulating adipogenesis by modulating the canonical Wnt/beta-catenin signaling pathway. BMC Genomics 2010; 11:320; PMID:20492721; http://dx.doi.org/10.1186/1471-2164-11-320.
96. Nakanishi N, Nakagawa Y, Tokushige N, Aoki N, Matsuzaka T, Ishii K, et al. The upregulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice. Biochem Biophys Res Commun 2009; 385:492-6; PMID:19460359; http://dx.doi.org/10.1016/j.bbrc.2009.05. 058.
97. Iliopoulos D, Drosatos K, Hiyama Y, Goldberg IJ, Zannis VI. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res 2010; 51:1513-23; PMID:20124555; http://dx.doi.org/10. 1194/jlr.M004812.
98. Kinoshita M, Ono K, Horie T, Nagao K, Nishi H, Kuwabara Y, et al. Regulation of adipocyte differentiation by activation of serotonin (5-HT) receptors 5-HT2AR and 5-HT2CR and involvement of microRNA-448-mediated repression of KLF5. Mol Endocrinol 2010; 24:1978-87; PMID:20719859; http://dx.doi.org/10.1210/me.2010-0054.
99. Sun T, Fu M, Bookout AL, Kliewer SA, Mangelsdorf DJ. MicroRNA let-7 regulates 3T3-L1 adipogenesis. Mol Endocrinol 2009; 23:925-31; PMID:19324969; http://dx.doi.org/10.1210/me.2008-0298.
100. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18:997-1006; PMID:18766170; http://dx.doi.org/10. 1038/cr.2008.282.
101. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 2010; 107:810-7; PMID:20651284; http://dx.doi.org/10.1161/CIRCRESAHA.110.226357.
102. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105:10513-8; PMID:18663219; http://dx.doi.org/10.1073/pnas.0804549105.
103. Stenvang J, Kauppinen S. MicroRNAs as targets for antisense-based therapeutics. Expert Opin Biol Ther 2008; 8:59-81; PMID:18081537; http://dx.doi.org/10.1517/14712598.8.1.59.
104. Czech MP, Aouadi M, Tesz GJ. RNAi-based therapeutic strategies for metabolic disease. Nat Rev Endocrinol 2011; 7:473-84; PMID:21502982; http://dx.doi.org/10.1038/nrendo.2011.57.
105. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007; 4:721-6; PMID:17694064; http://dx.doi.org/10.1038/nmeth1079.
106. Gumireddy K, Young DD, Xiong X, Hogenesch JB, Huang Q, Deiters A. Small-molecule inhibitors of microrna miR-21 function. Angew Chem Int Ed Engl 2008; 47:7482-4; PMID:18712719; http://dx.doi.org/10.1002/anie.200801555.